trending Market Intelligence /marketintelligence/en/news-insights/trending/dwOebbXKxlEu_6wSx0QoFg2 content esgSubNav
In This List

Catalyst Biosciences chairman stepping down; replacement named

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Catalyst Biosciences chairman stepping down; replacement named

Barry Selick is stepping down as a board member and chairman of Catalyst Biosciences Inc. on Feb. 15, 2018.

Current board member Augustine Lawlor will replace Selick as chairman.

Also, the company appointed Edward Williams as a board member, effective Jan. 1, 2018.

Williams was most recently senior vice president of biopharmaceuticals at Novo Nordisk Inc.